Print Page
2308
Targeted Therapy for Moderate to Severe Atopic Dermatitis
Saturday, March 4, 2017: 10:45 AM-12:00 PM
Georgia World Congress Center, Building B, Level 4, Rooms B405-B406
1.25 CME/CE
Symposium
Moderator:
Mark Boguniewicz , MD FAAAAI

Learning Objectives:
  1. Discuss the benefits of targeted therapy compared to current standards of care
  2. Discuss monoclonal antibody-based therapies in development for moderate to severe atopic dermatitis
10:45 AM
Targeting the Th2 Axis in Atopic Dermatitis
Lisa A. Beck, MD FAAAAI
Handouts
  • Emerging_Rx_PDF_Published[1].pdf (1.2 MB)
    • 11:05 AM
    Question & Answer
    11:10 AM
    Targeting the Itch
    Harald Renz, MD FAAAAI
    Handouts
  • AAAAI, Session 2308, 04.03.17 - Printed Handout.pdf (114.8 kB)
    • 11:30 AM
    Question & Answer
    11:35 AM
    Targeting the Th17/Th22 Axis
    Tao Zheng, MD FAAAAI
    11:55 AM
    Question & Answer
    See more of: Session
    << Previous Session | Next Session >>